5.0
Aug 9, 2021
Current employee, less than 1 year
San Francisco, CA
Recommend
CEO approval
Business Outlook
Pros
A novel approach to developing therapeutics via bone marrow (no other major companies are doing this the way Ossium is). Fast-paced startup environment (no two days are ever the same) Opportunity to develop life-saving therapies and make a real impact on individuals' lives Great team and internal mobility
Cons
All of the cons typical of an early-stage biotech (for example: Uncertainty of long-term clinical success). Also some challenges due to having two offices (SF and Indianapolis).